Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Debt Ratio (2016 - 2018)

Niagen Bioscience (NAGE) has disclosed Debt Ratio for 3 consecutive years, with 0.0 as the latest value for Q4 2018.

  • On a quarterly basis, Debt Ratio fell 34.36% to 0.0 in Q4 2018 year-over-year; TTM through Dec 2018 was 0.0, a 34.36% decrease, with the full-year FY2018 number at 0.0, down 34.36% from a year prior.
  • Debt Ratio was 0.0 for Q4 2018 at Niagen Bioscience, down from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.26 in Q1 2016 to a low of 0.0 in Q4 2018.
  • A 3-year average of 0.09 and a median of 0.0 in 2017 define the central range for Debt Ratio.
  • Biggest YoY gain for Debt Ratio was 34.36% in 2018; the steepest drop was 34.36% in 2018.
  • Niagen Bioscience's Debt Ratio stood at 0.26 in 2016, then tumbled by 98.1% to 0.0 in 2017, then plummeted by 34.36% to 0.0 in 2018.
  • Per Business Quant, the three most recent readings for NAGE's Debt Ratio are 0.0 (Q4 2018), 0.0 (Q4 2017), and 0.26 (Q1 2016).